We demonstrated that the transferred CD8+ T cells infiltrate the brain metastases, and that the systemic administration of anti-PD-L1 antibodies promotes the activation of CD8+ T cells, significantly enhancing the anti-tumor effect against brain metastases [29]. The gene discussed is CD8A; the disease is neoplasm.